Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

Poplack, D G; Sallan, S E; Rivera, G; Holcenberg, J; Murphy, S B; Blatt, J; Lipton, J M; Venner, P; Glaubiger, D L; Ungerleider, R; Johns, D

Poplack, D G; Sallan, S E; Rivera, G; Holcenberg, J; Murphy, S B; Blatt, J; Lipton, J M; Venner, P; Glaubiger, D L; Ungerleider, R; Johns, D.

Cancer Res ; 41(9 Pt 1): 3343-6, 1981 Sep.

Article in En | MEDLINE | ID: mdl-6973390

Subject(s)

Coformycin/therapeutic use; Leukemia, Lymphoid/drug therapy; Ribonucleosides/therapeutic use; Adenosine Deaminase Inhibitors; Adolescent; Adult; Child; Child, Preschool; Coformycin/adverse effects; Coformycin/analogs & derivatives; Drug Administration Schedule; Drug Evaluation; Female; Humans; Liver/drug effects; Lymphopenia/chemically induced; Male; Nausea/chemically induced; Pentostatin; Prognosis; Vomiting/chemically induced

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ribonucleosides / Leukemia, Lymphoid / Coformycin Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Year: 1981 Type: Article

Search on Google

XML

PubMed Links